About the HPV vaccine
HPV vaccine and protection
In June 2018, JCVI recommended that the HPV vaccination programme for girls be extended to include boys.
This recommendation followed a review of the evidence on the benefit of HPV vaccination preventing a number of cancers that affect both males and females.
The HPV vaccine also protects against over 90% of genital wart infections.
In June 2016, the JCVI advised that the Gardasil®9 vaccine was the preferred vaccine for the HPV programme, because of the additional health benefits that it provided in protecting against cancer-causing HPV types.
Some individuals may have started the course with Gardasil®.
JCVI have confirmed that both vaccines are suitable for the one-dose schedule.